ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition
Keywords: Head and neck cancer; PI3-kinase; Precision medicine; Extracellular signal-regulated MAP kinases; HRAS protein; Hotspot mutation; Genes; RAS; NVP-BYL719;